Table 2 Enzyme inhibitor activities of the 1,3,4-oxadiazole derivatives expressed as % of inhibition.

From: Structural and computational supported development of 2,5-disubstituted-1,3,4-oxadiazole analogues as active LOX, urease, and α-glucosidase inhibitors

Compounds

LOX

Inhibition (%)

at 0.25 mM

α-Glucosidase Inhibition (%)

at 0.5 Mm

Urease

Inhibition (%)

at 0.25 mM

7a

92.2 ± 0.5

89.42 ± 1.33

92.35 ± 1.65

7b

85.3 ± 0.3

67.35 ± 1.21

51.26 ± 1.39

7c

47.5 ± 0.8

45.42 ± 1.59

75.35 ± 1.52

7d

82.4 ± 0.6

72.35 ± 1.45

76.28 ± 1.43

7e

75.4 ± 0.6

66.38 ± 1.72

62.41 ± 1.57

7f

78.4 ± 0.7

78.79 ± 1.29

58.26 ± 1.45

7g

53.2 ± 0.4

67.54 ± 1.67

68.72 ± 1.58

7h

94.5 ± 0.6

62.35 ± 1.79

53.26 ± 1.35

7i

45.3 ± 0.6

84.87 ± 1.53

72.54 ± 1.45

7j

85.4 ± 0.7

63.25 ± 1.34

77.63 ± 1.23

7k

62.1 ± 0.6

56.49 ± 1.64

86.42 ± 1.55

7l

75.2 ± 0.4

75.67 ± 1.62

98.45 ± 1.69

7m

35.6 ± 0.7

63.84 ± 1.27

72.16 ± 1.45

7n

92.8 ± 0.8

89.54 ± 1.48

87.12 ± 1.76

7o

37.5 ± 0.4

52.65 ± 1.78

73.52 ± 1.63

Quercetin

89.2 ± 0.6

-

-

Acarbose

-

65.73 ± 1.93

-

Thiourea

-

-

98.21 ± 0.78